StonvexLoading…
StonvexStonvexStonvexCore line items from SLB's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $35.71B | $36.29B | $33.13B | $28.09B |
Operating Income | $4.29B | $5.67B | $6.52B | $5.01B |
Net Income | $3.37B | $4.46B | $4.20B | $3.44B |
EPS (Diluted) | $2.35 | $3.11 | $2.91 | $2.39 |
Total Assets | $54.87B | $48.94B | $47.96B | $43.13B |
Total Liabilities | $27.58B | $26.59B | $26.60B | $25.15B |
Cash & Equivalents | $3.04B | $3.54B | $2.90B | $1.66B |
Free Cash Flow OCF − CapEx | $4.79B | $4.67B | $4.70B | $2.10B |
Shares Outstanding | 1.50B | 1.40B | 1.43B | 1.42B |